"Get Ready for Japan" training programme

Physical activity is not only important for fitness but also for overall health. This is confirmed by a new study conducted under the leadership of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE).…

Prospects for personalized medicine in Crohn’s disease

The Charité BIH Innovation team established a new event series to expand the matching and connecting activities and to create a broader platform: The Future Tech Days – where digital health startups and members of Charité meet for a short pitch…

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…

- Berlin-based food tech company Formo develops fermentation processes to produce cheese alternatives.

- The €35 million EIB investment is backed by the European Union's InvestEU guarantee.

- This venture debt loan brings Formo’s total financing to…

Model was generated in only two months and sets new industry standard for performance

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab.

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves…